Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 5.04 +0.02 (0.40%)
Previous Close $5.02    52 Week High
Open $5.07    52 Week Low
Day High $5.12    P/E N/A 
Day Low $5.00    EPS
Volume 1,676,219       

(NASDAQ: TSHA) Delayed: 5.04 +0.02 (0.40%)
Previous Close $5.02    52 Week High
Open $5.07    52 Week Low
Day High $5.12    P/E N/A 
Day Low $5.00    EPS
Volume 1,676,219